← Leaderboards
Katherine Deigan Warner
Ribometrix, Llc
$1,646,141
Attributed
$1,646,141
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $690.4K · FY2016–19$1M$750K$500K$250K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$1,646,141 · 5
By mechanism
R21$605,950 · 2
R33$591,016 · 1
R43$449,175 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Therapeutic Target”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$399,079,477
- Judith S. Currier · University Of California Los Angeles$274,271,371
- Peter C Adamson · National Childhood Cancer Foundation$268,343,924
- Barbara Driver · Westat, Inc.$175,154,472
Research focus
Therapeutic TargetBaseVisionRibosomal RnaDrug DiscoveryGenomeSmall MoleculeUntranslated RnaResolutionTechnologyNucleotidesStructureFoundationsGoldDrug TargetingSmall Molecule TherapeuticsTherapeutic DevelopmentPropertyLigandsMapsPositioning AttributeProteinsNatural ProductsLead
Grant awards (7)
Allele-specific RNA-targeted lead compounds for Huntington's disease$201,386
R33 · FY2019 · NS · contact PI
Allele-specific RNA-targeted lead compounds for Huntington's disease$389,630
R33 · FY2018 · NS · contact PI
Targeting the HIV RNA genome using fragment-based ligand discovery$140,000
R21 · FY2018 · AI · contact PI
Allele-specific RNA-targeted lead compounds for Huntington's disease$260,150
R21 · FY2017 · NS · contact PI
An RNA-targeted platform for anti-flavivirus drug discovery$224,475
R43 · FY2017 · AI · contact PI
Targeting the HIV RNA genome using fragment-based ligand discovery$205,800
R21 · FY2017 · AI · contact PI
Shape RNA Structure Analysis for Drug Discovery and Translational Research$224,700
R43 · FY2016 · GM · contact PI